DIPG/DMG Collaborative
The DIPG/DMG Collaborative has funded basic, translational and clinical trials that further efforts in a homerun cure strategy for all cancers, starting with diffuse intrinsic pontine glioma and diffuse midline glioma. Our research is international and impactful, covering 129 institutions in 29 countries worldwide. The majority of our research focuses on $100,000 USD and $200,000 USD initiatives. We have also funded projects both with institutions and industry, provided that they meet grant requirements.
In an effort to balance innovation with transparency, we utilize the SnapGrant research application platform. SnapGrant currently offers free unlimited postings for our affiliated grant applications. These applications will be proprietary to The DIPG/DMG Collaborative affiliated funders. If The DIPG/DMG Collaborative declines funding your affiliated grant, it will be automatically released to public (non-affiliated) users of SnapGrant in a limited-view format with permission-based access that you approve on a case-by-case basis for potential funding (unless you elect to opt out during the application process).
ELIGIBILITY
- Must be an MD, DO, PhD, Dr, PH or equivalent
- Must be a member of a non-profit organization or a valid medical/scientific organization.
- Must be up to date with any previous funding through the DIPG/DMG Collaborative and any member organization, which includes progress report submissions.
HOW TO APPLY
- Applications must be submitted as a researcher account within the SnapGrant system
- Grants must be assigned the "DIPG/DMG Collaborative" affiliation when posting within SnapGrant
- Submit grant applications by June 1 of each year (grant may be submitted year-round but reviews may be limited to those submitted by June 1)
REQUIREMENTS
- Single spaced
- In English
- See additional requirements within